Tumor Ablation Market Size Worth $2.4 Billion By 2028 | CAGR: 13.2%: Grand View Research, Inc.

SAN FRANCISCO, Feb. 4, 2021 /PRNewswire/ -- The global tumor ablation market size is estimated to reach USD 2.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028. The increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market growth. According to Cancer Research U.K., the incidence rate of cancer is expected to grow by 62.0% from 2018 to 2040. Lung, breast, bowel, and prostate are the most common sites reported with cancer in 2018.


Key suggestions from the report:

    --  Radiofrequency dominated the technology segment and accounted for the
        largest revenue share of 35.5% in 2020 owing to prominent application in
        solid tumor removal
    --  Percutaneous procedures are expected to witness lucrative growth over
        the forecast period due to rising demand for minimally invasive
        procedures offering faster recovery and higher safety
    --  The lung cancer segment is anticipated to witness the fastest growth
        over the forecast period
    --  A sedentary lifestyle, increasing incidences of smoking, and rising air
        pollution are the factors contributing to the growing prevalence of lung
    --  North America dominated the market owing to factors such as the
        increasing prevalence of cancer, high purchasing power parity,
        government support for quality healthcare, and availability of

Read 120 page research report with ToC on "Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Radiofrequency, Microwave), By Treatment (Surgical, Laparoscopic), By Application, By Region, And Segment Forecasts, 2021 - 2028" at: https://www.grandviewresearch.com/industry-analysis/tumor-ablation-market

Increasing inclination towards minimally invasive procedures owing to benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the forecast period. Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings. This is expected to significantly eliminate the cost to the patient including hospital stays.

Supportive government initiatives such as screening programs, awareness campaigns, and cancer schemes for various cancer types are expected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) started offering lung cancer screening programs in some areas of England. Such initiatives are anticipated to escalate the need for cancer management in the early cancer stages, thereby driving the market.

The rising demand for advanced medical technologies coupled with improving financing capabilities of healthcare facilities is expected to increase the demand for medical devices being used for the treatment of tumors, during the forecast period. For instance, Maimonides Medical Centre, New York announced the purchase of advanced High Intensity Focused Ultrasound (HIFU) ablation device (Focal One by EDAP TMS SA) in 2019, becoming the second hospital in the U.S. to be equipped with HIFU technology.

Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region:

    --  Tumor Ablation Technology Outlook (Volume, Units; Revenue, USD Million,
        2016 - 2028)
        --  Radio frequency
        --  Microwave
        --  Cryoablation
        --  Irreversible Electroporation
        --  Other Ablation Technologies
    --  Tumor Ablation Treatment Outlook (Revenue, USD Million, 2016 - 2028)
        --  Surgical ablation
            --  Kidney Cancer
            --  Liver Cancer
            --  Breast cancer
            --  Lung Cancer
            --  Prostate Cancer
            --  Other cancers
        --  Laparoscopic Ablation
            --  Kidney Cancer
            --  Liver Cancer
            --  Breast cancer
            --  Lung Cancer
            --  Prostate Cancer
            --  Other cancers
        --  Percutaneous Ablation
            --  Kidney Cancer
            --  Liver Cancer
            --  Breast cancer
            --  Lung Cancer
            --  Prostate Cancer
            --  Other cancers
    --  Tumor Ablation Application Outlook (Revenue, USD Million, 2016 - 2028)
        --  Kidney Cancer
        --  Liver Cancer
        --  Breast cancer
        --  Lung Cancer
        --  Prostate Cancer
        --  Other cancers
    --  Tumor Ablation Regional Outlook (Revenue, USD Million, 2016 - 2028)
        --  North America
            --  U.S.
            --  Canada
        --  Europe
            --  U.K.
            --  Germany
            --  France
            --  Italy
            --  Spain
            --  Russia
            --  Netherland
            --  Switzerland
            --  Belgium
            --  Hungary
        --  Asia Pacific
            --  Japan
            --  China
            --  India
            --  Thailand
            --  South Korea
            --  Taiwan
            --  Singapore
            --  Malaysia
            --  Indonesia
            --  Philippines
        --  Latin America
            --  Brazil
            --  Mexico
            --  Argentina
            --  Colombia
            --  Chile
        --  Middle East & Africa
            --  South Africa
            --  Saudi Arabia
            --  UAE
            --  Turkey
            --  Israel

List of Key Players of Tumor Ablation Market

    --  Galil Medical Inc.
    --  Misonix Inc.
    --  HealthTronics
    --  Mermaid Medical
    --  Theraclion
    --  Chongqing Haifu Medical Technology Co., Ltd.
    --  HS Hospital Service S.P.A
    --  EDAP TMS S.A.

Find more research reports on Medical Devices Industry, by Grand View Research:

    --  Image-Guided Therapy Systems Market - The global image-guided therapy
        systems market size was valued at USD 2.2 billion in 2020 and is
        expected to expand at a compound annual growth rate (CAGR) of 6.0% from
        2021 to 2028.
    --  MRI-Guided Neurosurgical Ablation Market - The global MRI-guided
        neurosurgical ablation market size was valued at USD 493.4 million in
        2019 and is expected to grow at a compound annual growth rate (CAGR) of
        7.3% from 2020 to 2027.
    --  Laparoscopic Devices Market - The global laparoscopic devices market
        size was valued at USD 5.94 billion in 2018 and is anticipated to expand
        at a CAGR of 6.6% over the forecast period.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

View original content:http://www.prnewswire.com/news-releases/tumor-ablation-market-size-worth-2-4-billion-by-2028--cagr-13-2-grand-view-research-inc-301222017.html

SOURCE Grand View Research, Inc.